BBC lawsuit: The British broadcaster said in a statement Tuesday morning that it will defend itself against President Trump’s ...

Universal Consulting Opportunities (UCO), a subsidiary of Stellar MLS, one of the largest and most influential multiple ...

Pfizer's latest narrative update leaves its fair value estimate steady at about $29.08 per share, even as analysts fine tune assumptions around the company’s long term trajectory. Slightly softer ...

Are y'all ready to go Beyond the Gates? WinterFest came and went without much winter, while both Tomás and Madison got their ...

A Fairfax Criminal Defense Attorney Fights Back Fairfax, United States – December 11, 2025 / David Deane Attorney at Law – ...

Alphabet finally has a credible differentiator in enterprise AI, something it has not enjoyed at scale in the past. Gemini ...

Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...

Ares Management has just been tapped for inclusion in the S&P 500, and the move has turned a steady alternative-asset manager ...

MBX Biosciences, Inc. is rated a Buy, driven by canvuparatide's once-weekly dosing advantage in hypoparathyroidism. Learn ...

Sir Keir Starmer is under growing pressure to intervene as Donald Trump files a defamation lawsuit against the BBC over its ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

It all started with a phone call. As a data guy by nature, it’s difficult to answer an opinion question like which state ...